IE54054B1 - Derivatives of 3-amino-1-heteroaryloxy-2-propanol - Google Patents
Derivatives of 3-amino-1-heteroaryloxy-2-propanolInfo
- Publication number
- IE54054B1 IE54054B1 IE2552/82A IE255282A IE54054B1 IE 54054 B1 IE54054 B1 IE 54054B1 IE 2552/82 A IE2552/82 A IE 2552/82A IE 255282 A IE255282 A IE 255282A IE 54054 B1 IE54054 B1 IE 54054B1
- Authority
- IE
- Ireland
- Prior art keywords
- diacetyl
- formula
- acid addition
- benzofuran
- amino
- Prior art date
Links
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 title 1
- 239000002876 beta blocker Substances 0.000 abstract description 11
- 229940097320 beta blocking agent Drugs 0.000 abstract description 10
- 239000002253 acid Substances 0.000 abstract description 4
- 150000003839 salts Chemical class 0.000 abstract description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 15
- 229960001317 isoprenaline Drugs 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- PMNVZOLFGAIFIF-UHFFFAOYSA-N 1-[4-acetyl-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1-benzofuran-2-yl]ethanone;hydrochloride Chemical compound Cl.CC(C)(C)NCC(O)COC1=CC=C2OC(C(=O)C)=CC2=C1C(C)=O PMNVZOLFGAIFIF-UHFFFAOYSA-N 0.000 description 9
- 102000005962 receptors Human genes 0.000 description 9
- 108020003175 receptors Proteins 0.000 description 9
- 230000000747 cardiac effect Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 230000033764 rhythmic process Effects 0.000 description 5
- YBOZCNFWCOEEAJ-UHFFFAOYSA-N 1-[4-acetyl-5-(3-amino-2-hydroxy-4-methylpentoxy)-1-benzofuran-2-yl]ethanone Chemical compound CC(C)C(N)C(O)COC1=CC=C2OC(C(C)=O)=CC2=C1C(C)=O YBOZCNFWCOEEAJ-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 3
- 238000010253 intravenous injection Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 3
- 229940076279 serotonin Drugs 0.000 description 3
- JGAPGCLZGXMAGI-UHFFFAOYSA-N 1-(4-acetyl-5-hydroxy-1-benzofuran-2-yl)ethanone Chemical compound OC1=CC=C2OC(C(=O)C)=CC2=C1C(C)=O JGAPGCLZGXMAGI-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- 208000009079 Bronchial Spasm Diseases 0.000 description 2
- 208000014181 Bronchial disease Diseases 0.000 description 2
- 206010006482 Bronchospasm Diseases 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000004882 diastolic arterial blood pressure Effects 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 229940105631 nembutal Drugs 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- SGRYAVPGRFMDKH-UHFFFAOYSA-N CC(C)NC=1C=C(C2=CC=CC=C2C=1)OCC(C)O Chemical compound CC(C)NC=1C=C(C2=CC=CC=C2C=1)OCC(C)O SGRYAVPGRFMDKH-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 101100518501 Mus musculus Spp1 gene Proteins 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003257 anti-anginal effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- WIRUZQNBHNAMAB-UHFFFAOYSA-N benzene;cyclohexane Chemical compound C1CCCCC1.C1=CC=CC=C1 WIRUZQNBHNAMAB-UHFFFAOYSA-N 0.000 description 1
- 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 description 1
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 description 1
- 229940030611 beta-adrenergic blocking agent Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 230000002057 chronotropic effect Effects 0.000 description 1
- 150000001907 coumarones Chemical class 0.000 description 1
- VGHOWOWLIXPTOA-UHFFFAOYSA-N cyclohexane;toluene Chemical compound C1CCCCC1.CC1=CC=CC=C1 VGHOWOWLIXPTOA-UHFFFAOYSA-N 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 231100001160 nonlethal Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229940084879 selective beta blocking agent Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8120471A FR2515649A1 (fr) | 1981-10-30 | 1981-10-30 | Nouveaux derives appartenant a la famille des 3-amino-1-heteroaryloxy-2-propanols, utilisation en therapeutique et procede de preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE822552L IE822552L (en) | 1983-04-30 |
| IE54054B1 true IE54054B1 (en) | 1989-05-24 |
Family
ID=9263594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2552/82A IE54054B1 (en) | 1981-10-30 | 1982-10-22 | Derivatives of 3-amino-1-heteroaryloxy-2-propanol |
Country Status (16)
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL300664A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1962-11-23 | |||
| FR1503510A (fr) * | 1962-11-23 | 1967-12-01 | Ici Ltd | Composés naphtaléniques et leur procédé de fabrication |
| US3853923A (en) * | 1971-05-13 | 1974-12-10 | Kakenyaku Kako Kk | 2-substituted-(2-hydroxy-3-lower alkaminopropoxy)-benzofurans |
-
1981
- 1981-10-30 FR FR8120471A patent/FR2515649A1/fr active Granted
-
1982
- 1982-10-22 IE IE2552/82A patent/IE54054B1/en unknown
- 1982-10-25 DE DE8282401959T patent/DE3266420D1/de not_active Expired
- 1982-10-25 AT AT82401959T patent/ATE15669T1/de not_active IP Right Cessation
- 1982-10-25 EP EP82401959A patent/EP0078735B1/fr not_active Expired
- 1982-10-26 GR GR69643A patent/GR76240B/el unknown
- 1982-10-27 CA CA000414274A patent/CA1197516A/en not_active Expired
- 1982-10-28 US US06/437,210 patent/US4485111A/en not_active Expired - Fee Related
- 1982-10-29 ES ES516988A patent/ES8307782A1/es not_active Expired
- 1982-10-29 FI FI823707A patent/FI72515C/fi not_active IP Right Cessation
- 1982-10-29 ZA ZA827930A patent/ZA827930B/xx unknown
- 1982-10-29 NO NO823611A patent/NO157419C/no unknown
- 1982-10-29 AU AU90082/82A patent/AU550498B2/en not_active Ceased
- 1982-10-29 DK DK481082A patent/DK481082A/da not_active Application Discontinuation
- 1982-10-29 NZ NZ202326A patent/NZ202326A/en unknown
- 1982-10-30 JP JP57191729A patent/JPS58121287A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GR76240B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-08-04 |
| IE822552L (en) | 1983-04-30 |
| ES516988A0 (es) | 1983-08-01 |
| NO157419C (no) | 1988-03-16 |
| DE3266420D1 (en) | 1985-10-24 |
| AU550498B2 (en) | 1986-03-20 |
| FR2515649B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-06-29 |
| FI823707L (fi) | 1983-05-01 |
| CA1197516A (en) | 1985-12-03 |
| NO823611L (no) | 1983-05-02 |
| AU9008282A (en) | 1983-05-05 |
| US4485111A (en) | 1984-11-27 |
| EP0078735B1 (fr) | 1985-09-18 |
| JPS58121287A (ja) | 1983-07-19 |
| ES8307782A1 (es) | 1983-08-01 |
| NO157419B (no) | 1987-12-07 |
| NZ202326A (en) | 1985-08-30 |
| FI72515B (fi) | 1987-02-27 |
| ATE15669T1 (de) | 1985-10-15 |
| DK481082A (da) | 1983-05-01 |
| EP0078735A1 (fr) | 1983-05-11 |
| ZA827930B (en) | 1983-08-31 |
| FR2515649A1 (fr) | 1983-05-06 |
| FI72515C (fi) | 1987-06-08 |
| FI823707A0 (fi) | 1982-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR890000020B1 (ko) | 아릴옥시-및 아릴티오-하이드록시프로필-피페라지닐 아세트아닐리드 및 그의 제조방법 | |
| US4034009A (en) | 4-Ureido-2-acyl phenoxypropanolamine | |
| JP2637737B2 (ja) | 新規な薬剤 | |
| DD144050A5 (de) | Verfahren zur herstellung von n-alkylierten aminoalkoholen | |
| US3974156A (en) | 2-(Substituted anilino) methylmorpholine compounds | |
| US4207343A (en) | 1-Phenyl-3-(substituted phenoxy)propylamines | |
| FR2479825A1 (fr) | Benzodioxanne 1,4 methoxy-2 propanolamines, leur preparation et leur application en tant que medicaments | |
| FR2459235A1 (fr) | Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique | |
| PL91560B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| US4558129A (en) | Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade | |
| US4067904A (en) | Alkylsulfonylphenoxypropanolamine derivatives | |
| CY1274A (en) | 3-indolyl-tertiary butylaminopropanols | |
| GB2030985A (en) | Substituted furans | |
| US4029808A (en) | Thienyl phenyl O-(aminoalkyl)-ketone oxime and furyl phenyl O-(aminoalkyl)-ketone oxime coronary vasodilators | |
| IE54054B1 (en) | Derivatives of 3-amino-1-heteroaryloxy-2-propanol | |
| FR2460294A1 (fr) | Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant | |
| FR2637596A1 (fr) | Methyl-4 ((aryl-4 piperazinyl-1)-2 ethyl)-5 thiazole et ses derives, leur procede de preparation et les medicaments en contenant | |
| IE52345B1 (en) | Alkanolamine derivatives | |
| US4431664A (en) | Compound with antiulcerogenic activity, process for the preparation thereof and pharmaceutical composition therefrom | |
| US4269855A (en) | (3-Alkylamino-2-hydroxypropoxy)-furan-2-carboxylic acid anilides and physiologically tolerated acid addition salts thereof and medicaments containing them | |
| US4353917A (en) | Amino derivatives of 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazole, their preparation, and formulations containing these compounds | |
| PL84223B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| FI62065C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara alylsulfonylfenoxipropanolaminer och deras syra-additionssa ltr | |
| US3959486A (en) | Method for producing β-adrenergic blockage with alkanolamine derivatives | |
| US4008329A (en) | Substituted cyclohexanes, pharmaceutical compositions containing them and method of treatment involving their use |